MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
BMRN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

BioMarin Pharmaceutical (BMRN) Ownership - Who owns BioMarin Pharmaceutical?

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3221
Web
https://www.biomarin.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.76B
P/E Ratio
40.05
Total Cash
2.22B
Projected Growth
0.68
Total Debt
1.44B
Revenue
3.24B
Risk (Beta)
0.16
Dividend Yield
N/A
Total Cash/Share
11.50
Total Debt/Equity
45.30
Revenue/Share
16.40 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
BMRN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for BMRN
A.I. Advisor
published General Information

General Information

a developer of innovative pharmaceuticals for serious diseases & medical conditions

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
770 Lindaro Street
Phone
+1 415 506-6700
Employees
3221
Web
https://www.biomarin.com